Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here



Markets Continue to Slide on Growing Credit Concerns

By Darren Wong | TradingMarkets.com
Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS

U.S. stocks have plunged the past two days after news from Europe showed the full extent of the credit crunch. Inter-bank rates in Europe shot way above target, causing the European Central Bank to inject billions of dollars in an effort to bring liquidity to cash-strapped markets.

Wall Street reacted negatively, as the Dow dropped over 300 points yesterday. Financials have been hit the hardest, with brokerage and banking stocks losing significant amounts of value.

Currently, the major averages have moved off of their intraday lows but continue to see downward pressure.

Crude oil futures for September delivery continued to fall losing 1.3% to $70.64 a barrel on concerns that reduced economic growth will hamper fuel demand. Gold futures for December delivery rose 1% to $679.30 an ounce.

Around Asia, Shanghai's Composite fell fractionally to close at 4,749.37, Hong Kong's Hang Seng index lost 2.9% to 21,792.71, and Tokyo's Nikkei index dropped 2.4% to 16,764.09.

Join TradingMarkets Director of Education, Steve Primo, as he teaches a number of quantitative strategies that can potentially give you an edge in your trading.

Sign up now for one of our free training classes and start learning how to become a better trader.

Stocks in Motion
NVIDIA (NVDA | Quote | Chart | News | PowerRating) Q2 Profit Nearly Doubles; Declares 3-for-2 Stock Split (full story). NVDA shares dropped 5.2%.

Biogen Idec (BIIB | Quote | Chart | News | PowerRating) Names Paul Clancy CFO (full story). BIIB shares lost 0.7%.

Pride International (PDE | Quote | Chart | News | PowerRating) To Sell 2 Units To GP Investments For $1 Bln (full story). PDE shares fell 0.3%.

Boston Scientific (BSX | Quote | Chart | News | PowerRating) Unwinding Merger With Advanced Bionics (full story). BSX shares lost 3.2%.

For more stories as they happen, go to our Breaking News section.


Market Snapshot

Dow

-71.46 13,199.22

NASDAQ

-7.11 2,549.38

S&P 500

-6.16 1,446.93

NYSE NASDAQ

Volume

2,241,176,000 1,453,875,000

Advances

844 1009

Declines

2357 1933

Up Volume

495 352

Down Volume

1509 960

New Highs

20 38

New Lows

375 221


Strongest/Weakest Industry Groups

Strongest Industries

Weakest Industries

Oil and Gas Equipment Consumer Services
Telecom Investment Brokerage- National
Internet Insurance Brokers
Economic News
Import Prices y/y +2.8% vs +2.5% consensus

Darren Wong
Associate Editor
darrenw@tradingmarkets.com

TradingMarkets subscribers have access to 16 quantitative stock indicators and another 17 quantitative market bias indicators. These indicators are derived from our proprietary database that includes millions of trades, and designed to give you a short-term trading edge.

Each day, we provide free open access to one of these proprietary stock indicators. If you would like to access all 16 stock indicators, 17 market bias indicators, along with many other tools, click here for a free 7-day TradingMarkets trial.


>> See more articles by Darren Wong
Stocks RSS
Related Articles
More Related Articles >>
PREMIER SPONSORED LINKS
TRADE CENTER
 
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.